Focused on developing and commercializing therapies for central nervous system disorders, the company markets drugs including Hetlioz for sleep-wake disorders and Fanapt for schizophrenia. Revenue is concentrated in a small portfolio of specialty pharmaceuticals, making regulatory decisions, patent ...
1 member of Congress has disclosed 3 trades in Vanda Pharmaceuticals Inc (VNDA), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-01-26 | DAVID P. JOYCE | sell | $15K – $50K |
| 2017-01-26 | DAVID P. JOYCE | sell | $100K – $250K |
| 2016-08-09 | DAVID P. JOYCE | sell | $1K – $15K |